MedTrace Logo

Special Investigation of Kaletra in Pregnant Women

NCT01076985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2012-01-18

Study results available
· View outcomes & findings →

Summary

This non-interventional, post-marketing observational study was conducted to obtain safety data from the use of lopinavir/ritonavir (Kaletra), in clinical practice, in pregnant women and their children in Japan.

Conditions

  • Human Immunodeficiency Virus

Interventions

DRUG

Lopinavir/ritonavir (Kaletra)

Lopinavir/ritonavir (LPV/r) evaluated separately in patients who were naive to previous antiretroviral treatment and those who were not.

Sponsors & Collaborators

Principal Investigators

  • Toshiro Maeda · Abbott Japan Co.,Ltd

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076985 on ClinicalTrials.gov